Virpax® Pharmaceuticals to Present at 2024 BIO International Convention [Yahoo! Finance]
Virpax Pharmaceuticals, Inc. (VRPX)
Company Research
Source: Yahoo! Finance
non-addictive products for pain management, post-traumatic stress disorder, central nervous system (CNS) disorders and viral barrier indications, today announced that it will be presenting at the upcoming Bio International Convention in San Diego on Monday, June 3 rd at 4:00 p.m. PT. Gerald W. Bruce, CEO of Virpax, will deliver the corporate presentation. Event: Virpax Presentation at the 2024 BIO International Convention Date: Monday, June 3rd Time: 4:00 p.m. PT Location: Theater 3 Mr. Bruce and team members will host meetings from June 3 rd through the 5 th . To schedule a meeting, please submit a meeting request through the BIO International meeting platform or contact betsy.brod@affinitygrowth.com About Virpax Pharmaceuticals Virpax is developing branded, non-addictive pain management products candidates using its proprietary technologies to optimize and target drug delivery. Virpax is initially seeking FDA approval for two prescription drug candidates that employ tw
Show less
Read more
Impact Snapshot
Event Time:
VRPX
Last Price
Price Change
Price Change%
Volume Shares
Max Up
Max Down
%
Volume Ratio
Performance Comparison
Updated
|
Event Day
Stock performance from the time of news release until the following 4pm ET market close
|
Last price at news event
|
Since Event
Multi-day stock performance from the time of the news release
|
|---|---|---|
|
EVENT DAY
Stock performance from the time of news release until the following 4pm ET market close
|
LAST
PRICE AT NEWS EVENT |
SINCE EVENT
Multi-day stock performance from the time of the news release
|
| Last Price | ||
| VWAP | ||
|
High:
|
Max Up |
High:
|
|
Low:
|
Max Down |
Low:
|
|
%
|
Post news range |
%
|
|
|
Price change |
|
|
|
Price Change Percentage |
|
|
|
S&P 500 (SPX) |
|
|
%
|
Volume ratio |
%
|
| Volume | ||
| Ticks | ||
|
|
Avg transaction size |
|
Don't Miss Out On The Next BIG Stock Move
Event day
Event Day Chart will not be displayed beyond 90-day period of the event
Performance since event
Time And Velocity Analysis
Be the first to know
Opt in for alerts from News Quantifed
Sign Up Today
Opt-in for
VRPX alerts
Learn More With NQ
Reading the Impact Report
Help Me Understand This Data
Help Me Understand This Data
How NQ Works
What is news-based trading?
And why is it so successful?
And why is it so successful?
Movers & Shakers
The biggest gainers and losers and WHY it moved
VRPX alerts
High impacting Virpax Pharmaceuticals, Inc. news events
Weekly update
A roundup of the hottest topics
VRPX
News
- Virpax® Pharmaceuticals to Present at 2024 BIO International ConventionBusiness Wire
- Virpax Pharmaceuticals, Inc. (NASDAQ: VRPX) had its "hold" rating re-affirmed by analysts at Maxim Group.MarketBeat
- Virpax Announces Pricing of $2.25 Million Public Offering [Yahoo! Finance]Yahoo! Finance
- Virpax Announces Pricing of $2.25 Million Public OfferingBusiness Wire
- Virpax Pharmaceuticals Reports 2024 First Quarter Results and Recent Developments [Yahoo! Finance]Yahoo! Finance
VRPX
Sec Filings
- 6/12/24 - Form ARS
- 6/12/24 - Form DEF
- 5/23/24 - Form SC
- VRPX's page on the SEC website